We are live on ! Find out more
FBB

Fulton Breakefield Broenniman Portfolio holdings

AUM $1.53B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+18.11%
3 Year Est. Return
+57.23%
5 Year Est. Return
+68.56%
10 Year Est. Return
+240.26%
AUM
$388M
AUM Growth
+$9.36M
Cap. Flow
+$1.48M
Cap. Flow %
0.38%
Top 10 Hldgs %
20.08%
Holding
137
New
6
Increased
66
Reduced
55
Closed
10

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$4.12M
2
PEP icon
PepsiCo
PEP
+$2.74M
3
IBB icon
iShares Biotechnology ETF
IBB
+$2.71M
4
KN icon
Knowles
KN
+$1.13M
5
C icon
Citigroup
C
+$528K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.79%
2 Industrials 10.55%
3 Consumer Staples 10.38%
4 Healthcare 10.38%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$8.67M 2.23%
284,420
+6,622
+2% +$197K
GE icon
2
GE Aerospace
GE
$362B
$8.34M 2.15%
67,200
+2,369
+4% +$293K
BMY icon
3
Bristol-Myers Squibb
BMY
$126B
$8.18M 2.11%
157,363
+2,813
+2% +$150K
JNJ icon
4
Johnson & Johnson
JNJ
$624B
$8.06M 2.08%
82,071
+1,359
+2% +$126K
PEP icon
5
PepsiCo
PEP
$184B
$7.84M 2.02%
93,846
+33,780
+56% +$2.74M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$7.49M 1.93%
59,928
+1,910
+3% +$223K
D icon
7
Dominion Energy
D
$62.8B
$7.41M 1.91%
104,444
-229
-0.2% -$15.6K
QCOM icon
8
Qualcomm
QCOM
$180B
$7.41M 1.91%
93,975
+569
+0.6% +$42.9K
COP icon
9
ConocoPhillips
COP
$146B
$7.38M 1.9%
104,983
+1,588
+2% +$106K
UNP icon
10
Union Pacific
UNP
$181B
$7.12M 1.84%
75,872
+1,358
+2% +$121K
WFC icon
11
Wells Fargo
WFC
$261B
$6.93M 1.79%
139,254
+1,823
+1% +$84.9K
VZ icon
12
Verizon
VZ
$183B
$6.85M 1.77%
143,951
+1,612
+1% +$76.2K
PFF icon
13
iShares Preferred and Income Securities ETF
PFF
$13.2B
$6.8M 1.75%
174,168
+8,745
+5% +$334K
DD
14
DELISTED
Du Pont De Nemours E I
DD
$6.58M 1.7%
103,311
+890
+0.9% +$54.4K
BAC icon
15
Bank of America
BAC
$430B
$6.57M 1.69%
382,049
+244,709
+178% +$4.12M
CVX icon
16
Chevron
CVX
$387B
$6.57M 1.69%
55,242
+735
+1% +$85.5K
RTX icon
17
RTX Corp
RTX
$282B
$6.46M 1.67%
87,845
+2,606
+3% +$187K
EMR icon
18
Emerson Electric
EMR
$81.2B
$6.42M 1.65%
96,064
+2,941
+3% +$194K
CLX icon
19
Clorox
CLX
$11.3B
$6.38M 1.65%
72,520
-542
-0.7% -$47.6K
MDLZ icon
20
Mondelez International
MDLZ
$77.1B
$6.38M 1.65%
184,723
+1,628
+0.9% +$55.6K
IBM icon
21
IBM
IBM
$194B
$6.24M 1.61%
33,908
-110
-0.3% -$19.4K
PETM
22
DELISTED
PETSMART INC
PETM
$6.21M 1.6%
90,069
+1,402
+2% +$92.9K
MCD icon
23
McDonald's
MCD
$187B
$6.18M 1.59%
63,015
-480
-0.8% -$45.9K
DOV icon
24
Dover
DOV
$26.6B
$6.13M 1.58%
92,898
-16,579
-15% -$1.03M
LOW icon
25
Lowe's Companies
LOW
$113B
$6.01M 1.55%
123,026
+352
+0.3% +$17K

Similar funds

Fulton Breakefield Broenniman's Q1 2014 Portfolio in Review

As of Q1 2014, Fulton Breakefield Broenniman held 137 positions worth $388M, up 2.5% from $379M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Fulton Breakefield Broenniman's Q1 2014 filing shows 6 new, 66 increased, 55 reduced and 10 closed positions. Its largest new stake was iShares Biotechnology ETF: 32,556 shares worth $2.56M. The largest sale was Walgreens Boots Alliance, an estimated $4.05M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Staples.

  • Fulton Breakefield Broenniman's largest Q1 2014 buy was iShares Biotechnology ETF: 32,556 shares worth $2.56M.
  • Fulton Breakefield Broenniman added most to Bank of America in Q1 2014, an estimated $4.12M increase.
  • Fulton Breakefield Broenniman's biggest Q1 2014 reduction was Dover, cutting an estimated $1.03M.
  • Fulton Breakefield Broenniman fully exited Walgreens Boots Alliance in Q1 2014, selling an estimated $4.05M.
  • Fulton Breakefield Broenniman's ten largest holdings make up 20% of its $388M portfolio in Q1 2014.
  • Fulton Breakefield Broenniman opened 6 new positions and closed 10 in Q1 2014.
  • Fulton Breakefield Broenniman's portfolio value rose 2.5% quarter-over-quarter to $388M.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2014, filed 25 Apr 2014.